Gut Microbiota: The Brain Peacekeeper by Chunlong Mu et al.
fmicb-07-00345 March 15, 2016 Time: 19:28 # 1
REVIEW
published: 17 March 2016
doi: 10.3389/fmicb.2016.00345
Edited by:
Dimitrios Georgios Karpouzas,
University of Thessaly, Greece
Reviewed by:
Konstantinos Ar. Kormas,
University of Thessaly, Greece
Angel Valverde,
University of Pretoria, South Africa
*Correspondence:
Weiyun Zhu
zhuweiyun@njau.edu.cn
Specialty section:
This article was submitted to
Systems Microbiology,
a section of the journal
Frontiers in Microbiology
Received: 15 November 2015
Accepted: 04 March 2016
Published: 17 March 2016
Citation:
Mu C, Yang Y and Zhu W (2016) Gut
Microbiota: The Brain Peacekeeper.
Front. Microbiol. 7:345.
doi: 10.3389/fmicb.2016.00345
Gut Microbiota: The Brain
Peacekeeper
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Jiangsu Key Laboratory of Gastrointestinal Nutrition and Animal Health, Laboratory of Gastrointestinal Microbiology, College
of Animal Science and Technology, Nanjing Agricultural University, Nanjing, China
Gut microbiota regulates intestinal and extraintestinal homeostasis. Accumulating
evidence suggests that the gut microbiota may also regulate brain function and
behavior. Results from animal models indicate that disturbances in the composition
and functionality of some microbiota members are associated with neurophysiological
disorders, strengthening the idea of a microbiota–gut–brain axis and the role of
microbiota as a “peacekeeper” in the brain health. Here, we review recent discoveries
on the role of the gut microbiota in central nervous system-related diseases. We also
discuss the emerging concept of the bidirectional regulation by the circadian rhythm
and gut microbiota, and the potential role of the epigenetic regulation in neuronal cell
function. Microbiome studies are also highlighted as crucial in the development of
targeted therapies for neurodevelopmental disorders.
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INTRODUCTION
The collective genome of the gut microbiota is estimated to contain many more genes than the
human genome (Xu and Gordon, 2003). Gut microbiota is functionally diverse and participates
in carbohydrate metabolism, fiber degradation, and immune maintenance. In addition, gut
microbiota has also been implicated in regulating neurophysiological-governed behaviors, such
as stress, autism, pain, and multiple sclerosis (Cryan and Dinan, 2012). Gut microbiota is found
to regulate the neurophysiological behaviors through immune, endocrine and neural pathways
(Collins et al., 2012). It is now clear that the gut–brain communication is bidirectional. On one
hand, changes in the microbial community affect behavior. On the other hand, perturbations
in behavior alter the composition of the gut microbiota (Collins and Bercik, 2009). However,
the microbial community is affected by many environmental factors and host-related factors
(physiological status; Lozupone et al., 2012). Since changes in the composition of the gut microbiota
are associated with the behavioral and cognitive alterations (Cryan and Dinan, 2012), a healthy
microbiota community is essential for a normal regulation of the microbiota–gut–brain axis.
Among the potential factors regulating the axis, microbial metabolites may be the major mediators
(Cryan and Dinan, 2012). In this review, we discuss recent studies on the microbial regulation
of the brain health and the potential of the host-microbiota interaction in regulating various
neurophysiological behaviors, highlighting the role of the gut microbiota as a “peacekeeper” in
regulating the brain-controlled function and behavior.
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GUT MICROBIOTA AND FACTORS THAT
DRIVE VARIATIONS IN MICROBIOTA
COMPOSITION
The gut contains more than 1,000 bacterial species, as being
identified by culture-independent approaches (Rajilic-Stojanovic
and de Vos, 2014). Firmicutes and Bacteroidetes are the
predominant phyla (Collins et al., 2012). The distribution
of the gut microbiota shows the spatial and temporal
variation in both humans (Eckburg et al., 2005; Yatsunenko
et al., 2012) and rodents (Gu et al., 2013; Maurice et al.,
2015). Nonetheless, different microbes with metabolic and/or
immunological regulation abilities colonize the gut, generating
a complex interaction network within the microbes or between
the gut microbiota and the host. The complexity of the
microbial community, together with its diversity, stability,
and resilience, enables the gut microbiota to adapt readily
to the gut environment (Lozupone et al., 2012). A typical
mutualism interaction is the degradation of fiber in the gut.
Fiber degradation occurs through a mutualism interaction
with the host, whose digestion system itself does not have
this function (Velasquez-Manoff, 2015). To complement the
deficiency, intestinal microbes use glycoside hydrolases and
polysaccharide lyases to degrade the fiber into short-chain fatty
acids while these acids benefit the host (El Kaoutari et al., 2013).
The resilience ability is also an important property of the gut
microbiota. The ability of certain microbiota members which
dephosphorylate lipopolysaccharide (LPS) is important for the
microbiota resilience during inflammation-induced disturbance
(Cullen et al., 2015).
Recent advances in “omics” have expanded our knowledge
of the multitude functions of the gut microbiota. Within
the gut microbiota, some members, such as Lactobacillus and
Bifidobacterium species, are widely used as probiotics to promote
intestinal homeostasis (Bron et al., 2012). Others, such as
Akkermansia muciniphila (Derrien et al., 2008) and Bacteroides
thetaiotaomicron (Marcobal et al., 2011), are well-known for
their role in the mucin degradation. Clearly, the gut microbiota
adapts well in the gut with varying functions. Identification and
clarification of these functions provide the basis for manipulating
microbiota in order to maintain homeostasis and contribute to
setting the targets for developing the therapy against disorders.
Various factors, such as genotype, diet, inflammation, and
time of feeding, affect the microbiota community (Figure 1),
as discussed below. Take the genotype as an example, the
inbred mice with different genetic backgrounds own different
composition of the gut microbiota in the cecal lumen (Campbell
et al., 2012). Diet is known to affect the composition of the gut
microbiota. We find that a high-protein diet alters the colonic
microbiota in rats (Mu et al., 2016). In pig models, the pig
breed (Yang et al., 2014a) and dietary differences in the amount
of starch (Sun et al., 2015) affect the composition of the gut
microbiota. Other studies which use a pig model, the composition
of the gut microbiota from different sites, such as the lumen
and epithelial wall, varies, as well as their ability to utilize amino
acids (Dai et al., 2013; Yang et al., 2014b). Pathogen infection
also changes the microbial community. Citrobacter rodentium
infection increases the abundance of Enterobacteriaceae in the
colon of mice (Lupp et al., 2007). A recent research shows
that feeding patterns alter the daily cyclical composition of the
gut microbiota in mice (Zarrinpar et al., 2014). These facts
indicate that multiple variables affect the composition of the
gut microbiota. Additionally, the aforementioned factors can
also affect the intestinal function, enteric nervous system (ENS)
function, and central nervous system (CNS) function.
THE GUT MICROBIOTA IS ESSENTIAL
FOR ENTERIC AND CENTRAL NERVOUS
SYSTEM DEVELOPMENT
The primary evidence of the gut microbiota as a brain
peacekeeper is the discovery that gut microbiota regulates
nervous system development. Indeed, gut microbiota regulates
postnatal and adult development of the ENS in rats and mice
(Dupont et al., 1965; Neufeld et al., 2013; Collins et al., 2014).
The ENS controls intestinal motility and signals to the CNS.
The myenteric plexus of the jejunum and ileum of germ free
(GF) mice is abnormal compared to that of specific pathogen-
free (SPF) mice. The abnormality is related to a decrease in
the nerve density and the number of neuronal cell bodies per
ganglion, while an increase in nitrergic neurons on postnatal day
3 (Collins et al., 2014). In addition, gut microbiota may also affect
enteric glial cells. Enteric glial cells are essential components of
the ENS and act as a link in the gut–brain axis (Collins et al.,
2012). The gut microbiota in the ileum is able to regulate both
the initial colonization and homeostatic flow of glial cells in
the intestinal mucosa of mice (Kabouridis et al., 2015). In GF
mice, the average number and density of mucosal enteric glial
cells are significantly reduced compared to that of normal mice
(Kabouridis et al., 2015). This finding suggests that microbiota
and microbial products may potentially affect gastrointestinal
homeostasis via enteric glial cells. Furthermore, enteric glial cells,
at least in the ileum, link microbial cues with the host’s nervous
system. However, further research is required to determine the
nature of the relationship between enteric glial cells and abnormal
intestinal diseases or neuropsychiatric disorders.
Gut microbiota can also regulate the survival of enteric
neurons and the gastrointestinal motility, possibly through its
recognition by toll-like receptors. The depletion of the gut
microbiota by antibiotics leads to ENS anomalies and at the
same time decreases the expression of glial cell line-derived
neurotrophic factor (GDNF; Brun et al., 2013). An another
study shows that GF mice, wild-type mice depleted of the gut
microbiota, and Tlr4-deficient mice have delayed gastrointestinal
motility and reduced numbers of nitrergic neurons (Anitha et al.,
2012). However, LPS treatment promotes the survival of enteric
neurons through the TLR4-nuclear factor-kappa B pathway
(Anitha et al., 2012). Therefore, the TLR4-mediated interaction
between enteric neurons and microbiota may be important for
the function of the ENS.
It is worth noting that gut microbiota also regulates the
permeability of the blood–brain barrier in mice. The GF mice
have a lower expression of occludin and claudin-5 in the frontal
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FIGURE 1 | Factors driving the variation of gut microbiota may affect
brain function. Antibiotics and probiotics treatment are microbiota-targeted
interventions.
cortex, striatum, and hippocampus than SPF mice (Braniste et al.,
2014). The integrity of tight junctions is essential for maintaining
the blood–brain barrier function. In GF mice, monocolonization
by Clostridium tyrobutyricum or Bacteroides thetaiotaomicron,
and sodium butyrate treatment in mice decrease the permeability
of the blood–brain barrier as compared to that of control GF
mice by up-regulating tight junction proteins (Braniste et al.,
2014). These results suggest that the gut microbiota or microbial
products may be essential for establishing normal blood–brain
barrier permeability.
GUT MICROBIOTA IS INVOLVED IN
BEHAVIORAL REGULATION
The GF model provides a direct way to study how gut microbiota
regulates behavior (Cryan and O’Mahony, 2011). In GF rodents,
the expression of the hypothalamic corticotrophin-releasing
factor (CRF) gene is up-regulated, while the concentration
of circulating corticosterone is increased after acute stress, as
compared to that of SPF rodents (Sudo et al., 2004; Clarke et al.,
2013; Crumeyrolle-Arias et al., 2014). These changes lead to
elevated activity of the hypothalamic–pituitary–adrenal axis. In
practice, the GF rodent and their SPF counterparts are commonly
used to compare the response to anxiety. However, the results
show some discrepancies.
Previous studies have demonstrated the reduced anxiety in GF
female Swiss mice (Neufeld et al., 2011; Clarke et al., 2013) and GF
male NMRI mice (Heijtza et al., 2011) compared to SPF mice. On
the contrary, other studies find the increased anxiety in GF male
F344 rats (Crumeyrolle-Arias et al., 2014) and GF BALB/c mice
(Nishino et al., 2013). Several factors, including the methodology
and genetic backgrounds of the animals, have been proposed
to explain the reported differences (Crumeyrolle-Arias et al.,
2014). With regard to the genetic background, the F344 rat and
BALB/c mice may be genetically prone to anxiety, whereas the
NMRI and Swiss mice may be less prone to anxiety (Crumeyrolle-
Arias et al., 2014). Collectively, these findings suggest that the
gut microbiota affects the sensitivity of rodents to stress-induced
anxiety. However, some of the aforementioned studies of GF and
SPF rodents do not explore the composition of the gut microbiota
of the SPF group. Studies have also failed to consider the effect of
different strains and diets on the functional capacity of the gut
microbiota and their metabolites.
As well as regulating the stress-related behavior, the gut
microbiota also regulates appetite by affecting the production
of gut hormones, indicating a paradigm of the microbiota–gut–
brain axis. Appetite is modulated largely by the gut–brain axis,
a core function that controls energy homeostasis by balancing
energy intake and energy expenditure, so as to maintain energy
reserves (Abizaid et al., 2006; Morton et al., 2006). It is known that
gut hormones can regulate appetite (Murphy and Bloom, 2006).
Gut hormones are produced by enteroendocrine cells, which exist
along the intestinal mucosa from the stomach to the distal colon
and account for about 1% of gut mucosal cells (Vrieze et al.,
2010).
The gut hormones peptide tyrosine-tyrosine (PYY) and
glucagon-like peptide 1 (GLP-1) are produced in gut L cells
and exert anorectic functions (Murphy and Bloom, 2006). PYY
and GLP-1 bind receptors in the nerve ends of ENS and
transmit nutrient signals to the hypothalamo-brain stem network
along the vagus nerve, thus regulating appetite (Rasoamanana
et al., 2012). The microbial products from degradation and
fermentation of dietary fiber, such as acetate, propionate,
and butyrate, affect the production of PYY and GLP-1. For
example, acetate and butyrate are sensed by the G protein-
coupled receptors GPR41 and GPR43, which then induce
PYY and GLP-1 (Cani et al., 2013). Colon-derived acetate
induces the up-regulation of pro-opiomelanocortin and down-
regulation of agouti-related peptides in the hypothalamus, which
lead to appetite suppression (Frost et al., 2014). In healthy
humans, colonic delivery of propionate increases the plasma
level of PYY and GLP-1, and decreases appetite (Chambers
et al., 2014). In vitro, propionate induces the production of
PYY and GLP-1 from primary cultured human colonic cells
(Chambers et al., 2014). Propionate feeding also activates
intestinal gluconeogenesis gene expression via a gut–brain neural
circuit, which is dependent on GPR41 signaling in rats (De
Vadder et al., 2014). Although acetate, propionate, and butyrate
can affect gut hormone, their direct impact on neural function
is unclear. A study in cultured PC12 cells shows that propionate
and butyrate treatment affect the expression of genes involved in
catecholaminergic neurotransmission (Nankova et al., 2014).
In summary, the literatures suggest that both the microbiota
community and microbial metabolites are involved in mediating
the microbiota–gut–brain axis during appetite regulation.
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GUT MICROBIOTA MANIPULATION
REGULATES BEHAVIOR AND
COGNITIVE FUNCTION
To understand the potential of microbiota manipulation in
treating psychiatric disorders, it is important to know how the
psychiatric disorders alter the composition of the gut microbiota.
It is also essential to understand whether the gut microbiota
is a causal factor for psychiatric disorders. If so, some key
members of the gut microbiota that are affected by the psychiatric
disorders may be of therapeutic importance for restoring a
normal microbiota community and behaviors. These topics will
be addressed as follows.
Behavioral and Cognitive Alterations
Affect Gut Microbiota
The changes in the composition of the gut microbiota during
psychiatric disorders have been widely recognized. For example,
the increase in Lactobacillus and decreases in Prevotella (Kang
et al., 2013), and the decrease in Bifidobacterium (Finegold
et al., 2010; Adams et al., 2011) are observed in children with
autism spectrum disorders (ASDs). Specifically, an increase in
fecal Enterobacteriaceae and Alistipes, and a decrease in fecal
Faecalibacterium and Ruminococcus are observed in patients with
major depressive disorder, which are accompanied by a low level
of brain-derived neurotropic factor (BDNF) in the blood (Jiang
et al., 2015). BDNF is a key neurotrophin involved in neuronal
growth and survival (Cryan and Dinan, 2012).
Exposure to stress is widely reported to reduce the abundance
of Lactobacillus species (Galley and Bailey, 2014), which raises
the possibility of using probiotic Lactobacillus sp. to alleviate
the stress response. Our previous study shows that weaning
stress reduces the abundance of Lactobacillus sp. in the stomach,
jejunum, and ileum, while increases the abundance of the
pathogen Streptococcus suis in the stomach of piglets (Su et al.,
2008b). Similar findings are also observed in the hindgut of
piglets after weaning (Su et al., 2008a). A related question is
the potential impact of maternal stress on the microbiota of
newborns. In a study using a primate model, prenatal stress by
acoustical startle in female monkeys leads to decreased numbers
of bifidobacteria and lactobacilli in the feces of infant monkeys
(Bailey et al., 2004). However, such results should be interpreted
cautiously, due to the reason that the results about bacterial
processes in the gut cannot be simply based on analyses of fecal
bacteria. In rhesus macaque, the fecal bacterial community shows
a strong correlation with that of the colonic lumen and mucosa
and a moderate correlation with that of the distal small intestine
(Yasuda et al., 2015). The microbiota at specific sites in the gut
should be studied when examining gut bacterial processes in the
gastrointestinal tract. These alterations in microbiota members
under certain disease condition can provide an indicator for a
clinical diagnosis.
Beyond the impact on the microbial communities, psychiatric
comorbidity may also affect colonic functions. In a mouse
model of depression using olfactory bulbectomy female C57BL/6
mice, changes in neural behavioral increase colonic muscle
contractility and tissue serotonin concentration and alter the fecal
microbiota profile, but have no effect on the mRNA expression
of proinflammatory or anti-inflammatory cytokines (Park et al.,
2013). The intracerebroventricular infusion of corticotrophin-
releasing hormone, which is up-regulated in the hypothalamus
in mouse models of depression, to wild-type mice also induces
anxiety-like behavior and alters colonic function and fecal
microbiota profiles (Park et al., 2013). The authors propose that
stress-related alterations in the colonic motility may explain the
changes in the microbiota profiles.
Microbiota Disturbance and Host
Inflammation are Involved in Behavior
Alteration
Although, alterations in the microbiota community are widely
reported in those with psychiatric disorders, whether microbiota
is a casual factor in regulating neurophysiological behavior is
not clear. A recent study in obesity suggests that microbiota
tends to be a causal factor in regulating obesity-associated
neuropsychiatric disorders (Bruce-Keller et al., 2015). Obesity
is linked to an increased risk of neuropsychiatric disorders,
such as depression, dementia, and brain pathology (Bruce-
Keller et al., 2009). The transplantation of the gut microbiota
from HFD-fed mice to recipient mice (microbiota depletion
by antibiotics) disrupts exploratory, cognitive, and stereotypical
behavior compared to mice given microbiota from a control
diet (Bruce-Keller et al., 2015). Moreover, HFD microbiota
down-regulates the protein expression of occludin in the
jejunum and colon, up-regulates inflammatory markers in the
colon, increases plasma endotoxin and neuroinflammation, and
disrupts cerebrovascular homeostasis (Bruce-Keller et al., 2015).
Thus, it seems that compared to the jejunum, alterations in the
colonic epithelial barrier may have a more detrimental effect
on inflammation. It also establishes a robust link between gut
dysbiosis and neurological dysfunction, and indicates the role of
microbiota as a brain peacekeeper.
Other studies on the infection of enteric pathogens also
suggest a potential relationship between gut dysbiosis and
neurological dysfunction. Pathogen infection induces anxiety-
like behavior and changes in the composition of the gut
microbiota. Anxiety-like behavior increases in mice infected
with Trichuris muris (Bercik et al., 2010), C. rodentium (Lyte
et al., 2006), and Campylobacter jejuni (Goehler et al., 2008),
respectively. C. rodentium infection increases the abundance of
Enterobacteriaceae in the colon of mice (Lupp et al., 2007).
C. rodentium infection also leads to stress-induced memory
dysfunction in mice (Gareau et al., 2011). T. muris induces
anxiety-like behavior via the vagus-independent pathway,
whereas the anxiety-related behavior induced by C. rodentium
seems to be vagus-dependent (Cryan and Dinan, 2012).
In a study of T. muris infection, host inflammation,
together with the altered microbiota profiles, are found
to contribute to the behavioral regulation (Bercik et al.,
2010). During T. muris infection, etanercept treatment
normalizes the behavior and reduces the plasma level of
proinflammatory cytokines (tumor necrosis factor α), while
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does not influence hippocampal Bdnf mRNA expression.
Interestingly, the administration of probiotic Bifidobacterium
longum normalizes the behavior and Bdnf mRNA expression,
while does not affect the concentration of plasma cytokines
(Bercik et al., 2010). Therefore, both host inflammation and
probiotic function are involved in behavioral regulation.
These results hint that the combined therapy, with the host and
microbiota treated simultaneously, may be a possible approach to
normalize behavior and brain function in those with psychiatric
disorders.
Restoring the Gut Microbiota Balance
Benefits Normal Brain Function
The use of probiotic and antibiotic to restore the gut microbiota
balance can be an effective strategy to regulate anxiety and stress
response. As reviewed previously, probiotics treatment reduces
anxiety, decreases the stress response, and normalizes behavior,
in both humans and rodents (Cryan and Dinan, 2012; Luna
and Foster, 2015). For example, treatment with L. rhamnosus
reduces stress-induced anxiety- and depression-related behavior
via the vagus-dependent pathway, with the improvement related
to increased mRNA expression of gamma-aminobutyric acid
(GABA)Aα2 and decreased expression of GABAAα1 in the
hippocampus (Bravo et al., 2011). Another study shows that
treatment with Blautia coccoides alone reduces the anxiety level
in gnobiotic mice, whereas B. infantis has little effect on the
anxiety level (Nishino et al., 2013). During T. muris (Bercik
et al., 2010) and C. rodentium (Mackos et al., 2013) infection,
a probiotic treatment alleviates anxiety-like behavior and
normalizes the expression of hippocampal BDNF. Human studies
show that the treatment of healthy women with a probiotics
mix of Bifidobacterium animalis subsp. lactis, Streptococcus
thermophiles, Lactobacillus bulgaricus, and Lactococcus lactis
subsp. lactis is associated with changes in midbrain connectivity
during an emotional attention task (Tillisch et al., 2013).
Specifically, the administration of L. rhamnosus + L. helveticus
before and during C. rodentium infection prevents memory
dysfunction in mice (Gareau et al., 2011). Thus, these findings
confirm the existence of the microbiota-gut–brain axis. The
results establish the usefulness of probiotics as new medications
against anxiety.
The antibiotic treatment is another approach that modulates
the gut microbiota and brain function. Oral antimicrobials
increase exploratory behavior and the hippocampal expression
of Bdnf in SPF mice (Bercik et al., 2011). At the phylotype
level, antimicrobials increase the abundance of Firmicutes and
Actinobacteria and decrease γ-Proteobacteria and Bacteroidetes
in the colon (Bercik et al., 2011). Interestingly, antimicrobials
do not affect neurotransmitters and inflammatory cytokines in
the gut (Bercik et al., 2011). A potential mechanism may be that
changes in the microbiota or microbial products may be involved
in the increased hippocampal expression of Bdnf. During water
avoidance stress, antibiotics administration increases the quantity
of Lactobacillus and decreases Clostridium coccoides cluster XIVa,
with the two bacterial groups showing positive and negative
correlations, respectively, with the expression of cannabinoid
receptor type 2 (Aguilera et al., 2013). This finding points
to the modulation of the intestinal endocannabinoid system
by gut microbiota. Intracolonic stress induced by capsaicin
provokes visceral pain-related responses, which are absent with
antibiotic treatment in mice (Aguilera et al., 2013). Therefore,
gut microbiota is involved in regulating stress-induced visceral
hypersensitivity.
In a rat model using chronic water avoidance or repeat
restraint stressors, rifaximin administration increases the
expression of the tight junction protein occludin and decreases
the expression of proinflammatory interleukin 17, interleukin 6,
and tumor necrosis factor α mRNA in the distal ileum, which
alleviate visceral hyperalgesia (Xu et al., 2014). The effect of
rifaximin is associated with increased abundance of Lactobacillus
in the ileum. Some Lactobacillus species, such as L. casei, exert an
anti-inflammatory effect in intestinal mucosa (Llopis et al., 2009).
Collectively, these findings suggest that the use of probiotics may
help to regulate behaviors.
Modulation of the gut microbiota with certain microbe
may be adopted to treat ASDs. Some individuals with ASD
have comorbid gastrointestinal dysfunction (Coury et al., 2012).
In a mouse model of ASD, Bacteroides fragilis colonization
ameliorates abnormal communicative, stereotypical, and anxiety-
like behaviors in maternal immune activation offspring mice
(Hsiao et al., 2013). It also improves the integrity of the
gut barrier, down-regulates the proinflammatory response, and
restores the gut microbiota in the colon (Hsiao et al., 2013).
The amelioration induced by bacterial colonization is strain
dependent, as no such amelioration is observed following the
administration of Enterococcus faecalis. The administration of
a microbial product 4-ethylphenylsulfate, which increases in
response to poly (I:C) activation and seems to induce anxiety-
like behavior in wild-type mice, after B. fragilis administration
may explain the observed improvements following B. fragilis
colonization (Hsiao et al., 2013). The aforementioned study
points to microbiota-mediated regulation of ASD and related
gastrointestinal dysfunction.
In summary, the literatures show the importance of the
microbiota–gut–brain axis in regulating brain function.
The microbiota–gut–brain connection further provides
an opportunity for microbiota manipulation to treat
neurodevelopmental disorders. Importantly, the findings
that restoring the gut microbiota balance benefits normal brain
function further support our idea that the gut microbiota is an
important brain peacekeeper.
CIRCADIAN RHYTHMS AND GUT
MICROBIOTA: BIDIRECTIONAL
REGULATION
An increasing number of studies indicate the relationship
between circadian rhythms and gut microbiota. The physiological
circadian rhythm regulates daily events, including feeding,
hormone secretion, and metabolic homeostasis (Liang et al.,
2015). The physiological condition can change in response to
the oscillation of light during a 24-h cycle. Intestinal functions,
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such as nutrient absorption and motility, are regulated in a
circadian manner (Hussain and Pan, 2009). In particular, food
entrainment may link the circadian rhythms of the intestine with
the dorsomedial hypothalamus, providing a potential means of
the gut–brain communication (Hussain and Pan, 2009).
Alterations in dietary habitats and circadian rhythms may
potentially affect the composition of the microbiota community,
consequently affecting the host’s metabolism (Thaiss et al., 2014;
Liang et al., 2015).
The gut microbiota shows cyclical fluctuations in response
to changes in diets or feeding patterns. For instance, the HFD
changes diurnal patterns of the gut microbiota in mice (Leone
et al., 2015). The HFD also impairs the expression of central
and hepatic circadian clock gene in GF mice (Leone et al.,
2015). In this case, short-chain fatty acids derived from the
microbial metabolism can modulate the expression of circadian
clock genes in hepatocytes (Leone et al., 2015). Except for diets,
feeding patterns may also change the microbial communities.
Time-restricted feeding restores the cyclical fluctuation of the
gut microbiota, which is diminished by HFD-induced obesity
(Zarrinpar et al., 2014). The restoration of the gut microbiota
is accompanied by an increase in the concentration of galactose,
deoxycholate, and taurocholate in feces (Zarrinpar et al., 2014).
Interestingly, the host circadian clock in mice regulates
microbial circadian rhythmicity (Liang et al., 2015). Bacteroidetes
is more predominant during the daytime than at evening time,
and variations in the level of Bacteroidetes during the day are the
main driving force of circadian oscillations in the total bacterial
load (Liang et al., 2015). The deletion of Bmal1, one of the core
components of the mammalian clock, abolishes the rhythmicity
in the fecal microbiota composition, especially in female mice
(Liang et al., 2015). Similarly, a deficiency of clock gene Per1/2
or induction of jet lag in mice leads to aberrant microbiota
diurnal fluctuations and dysbiosis (Thaiss et al., 2014). The jet-
leg-induced microbiota dysbiosis promotes glucose intolerance
and obesity in both humans and mice (Thaiss et al., 2014). The
metabolic phenotype produced by jet-leg can be transferred to
GF mice by fecal transplantation (Thaiss et al., 2014), which
suggests the microbiota-dependent alteration in individuals with
abnormal circadian rhythms. This work also highlights the role of
diurnal variations in the microbial composition and function in
driving metabolic diseases.
The above findings indicate the importance of the host
circadian clock in regulating the composition of the gut
microbiota assembly. What’s more, the gut microbiota may be a
causal factor in regulating the components of circadian clock and
the host metabolism.
The ability of the gut microbiota to affect the circadian rhythm
is also demonstrated in the studies involved in the antibiotic
treatment. Microbiota depletion by antibiotics treatment is
associated with deficiencies in the expression of clock genes.
For example, microbiota depletion by antibiotics disrupts the
oscillatory profile of the transcript expression of TLRs (Tlr1-
5, Tlr9), TLR adaptors (interleukin-1 receptor-associated kinase
4), and inflammatory cytokines (Il-6, Il-1β, and regenerating
islet-derived 3 gamma) throughout the circadian cycle in ileal
intestinal epithelial cells (Mukherji et al., 2013). The rhythmic
TLR expression mediates microbiota cues to the downstream
activators, the c-Jun N-terminal kinase and the inhibitor of
nuclear factor-kappa B kinase β. The administration of LPS
following microbiota depletion restores the expression of TLRs
and clock components (Mukherji et al., 2013). These results
point to the essential role of the gut microbiota or microbial
cues in regulating the circadian clock. The circadian signals
between microbiota and host mucosa provide insight into clock-
controlled genes which regulate intestinal immune homeostasis.
These findings also expand our understanding of the role of the
gut microbiota as a brain peacekeeper.
It becomes clear that there is a bidirectional regulation
between circadian rhythm and gut microbiota. However, in case
of psychiatric disorders, whether anxiety and ASDs affect the
rhythmic oscillations of the gut microbiota, and consequently
change host health, is an intriguing question to be further studied.
EPIGENETIC REGULATION OF
NEURONAL CELL FUNCTION
Epigenetic regulation is involved in the regulation of the nervous
system (for a review, see Stilling et al., 2014). MicroRNAs exert
the epigenetic regulation by post-transcriptionally regulating
gene expression of the target mRNAs (Liu and Xu, 2011).
They are known to regulate the immune response, epithelial
differentiation, CNS trauma, and degenerative disorders (Biton
et al., 2011; Liu and Xu, 2011). In neurodegenerative diseases,
microRNAs also regulate the survival of neuronal cells, such as
Mir433 in Parkinson’s disease and Mir9 in Huntington’s disease
(Packer et al., 2008). The presence of the gut microbiota induces
the expression of Mir145 in the murine cecum (Singh et al.,
2012). Mir145 is important in neural crest function (Strobl-
Mazzulla et al., 2012). However, the direct role of the gut
microbiota in regulating microRNAs in the nervous system is
unclear.
It is possible that the microbial product will affect the
components of nervous system. The microbial product butyrate
can induce the expression of Mir375 in differentiated human
embryonic stem cells (Tzur et al., 2008). The induction of
Mir375 promotes colonic goblet-cell maturation during T. muris
infection in wild- type mice (Biton et al., 2011). Butyrate
appears to regulate the number of choline acetyltransferase-
immunoreactive myenteric neurons, possibly acting as a histone
deacetylase inhibitor (Soret et al., 2010). The expression of
histone deacetylase 3 is essential for the barrier function
of intestinal epithelial cells, paneth cells development, and
maintaining a balanced microbiota (Alenghat et al., 2013). Thus,
the epigenetic regulation by butyrate may link the function of the
gut microbiota to the nervous system.
A recent study on HFD indicate the role of saturated free
fatty acid in regulating the function of enteric neuron. In a mice
model, palmitate-induced apoptosis of enteric neurons, and the
apoptotic function of palmitate are mediated by HFD-induced
up-regulation of Mir375 (Nezami et al., 2014). As mentioned
earlier in this review, the dysbiosis of the gut microbiota induced
by HFD is associated with obesity-associated neuropsychiatric
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disorders (Bruce-Keller et al., 2015). Therefore, whether a link
exists between the gut microbiota, microRNA, and neural
regulation may be worthy of further investigation.
THE HOST-MICROBIOTA INTERACTION
MAY BE A KEY PROCESS IN MEDIATING
THE MICROBIOTA–GUT–BRAIN AXIS
The mechanisms by which the gut microbiota regulates the brain
health have been discussed previously (Cryan and Dinan, 2012).
They include pathways mediated by metabolites, the immune
system, and the vagus nerve (Cryan and Dinan, 2012). Based on
the literatures discussed above, we propose roles for a pattern
recognition receptor (PRR)-mediated interaction and a microbial
metabolite-mediated interaction in the microbial regulation of
brain health.
Pattern Recognition Receptor
(PRR)-Mediated Interaction: The
Microbiota-Associated Molecular
Pattern MAMP/PRR-Gut-Brain
Hypothesis
Pattern recognition receptors may be involved in mediating
the regulation of the gut microbiota. Microbiota-associated
molecular pattern (MAMP) and PRRs crosstalk is an essential
mechanism for host recognition of microbiota (Mu et al., 2015).
It is interesting to note that the intestinal bacteria, such as
Lactobacillus (Bravo et al., 2011), Bifidobacterium (Bercik et al.,
2010) and Blautia (Nishino et al., 2013), which are used as
probiotics to alleviate anxiety behavior, are gram-positive. It is
also found that stress exposure usually reduces the abundance
of Lactobacillus species (Galley and Bailey, 2014). Interestingly,
the bacteria enriched after antibiotic treatment are also gram-
positive, such as Lactobacillus (Llopis et al., 2009; Aguilera et al.,
2013; Xu et al., 2014). Such bacteria are known to produce the
lipoteichoic acid, a ligand of TLR2.
As shown by studies of Tlr2-deficient mice, TLR2 is important
in linking the epithelium function of the intestinal microbiota
and the ENS (Brun et al., 2013). TLR2 is expressed in enteric
neurons, glia, and smooth muscle in the ileum of C57BL/6J
mice (Brun et al., 2013). Tlr2 deficiency leads to the abnormal
architecture and neurochemical profile of the ENS, the intestinal
dysmotility, and the decreased levels of GDNF in smooth muscle
cells, as compared to wild-type mice (Brun et al., 2013). This
finding provides an important hint that the integrity of the ENS
depends on the microbiota-TLR2-GDNF axis. Furthermore, the
dysfunction of the ENS increases the sensitivity to chemical-
induced colitis (Brun et al., 2013). As reported earlier, the
microbiota dysbiosis in Crohn’s disease patients may affect the
normal structure of the ENS, thereby contributing to the spread
and exacerbation of the disease (Lakhan and Kirchgessner, 2010).
Based on the above results, we propose that the interaction
between lipoteichoic acid and TLR2 interaction may be involved
in mediating the microbiota–gut–brain axis. This hypothesis is
supported by a recent study demonstrating that lipoteichoic acid
treatment down-regulates the expression of phospho-protein
kinase B (PKB/AKT) and phospho- glycogen synthase kinase-
3α/β, which are up-regulated in a Tlr2-deficient mouse model of
schizophrenia (Park et al., 2015).
Microbial Metabolite-Mediated
Regulation
Bacteria which are capable of producing short-chain fatty
acids are undoubtedly regulators of appetite. Meanwhile,
microbiota-mediated tryptophan metabolism also regulates
neural function (Yano et al., 2015). The human gut bacteria
Clostridium sporogenes and Ruminococcus gnavus are capable
of decarboxylating tryptophan to tryptamine, a β-arylamine
neurotransmitter (Williams et al., 2014). Tryptamine induces
the release of serotonin by enterochromaffin cells (Takaki et al.,
1985). Stress can increase the availability of serotonin in the colon
(Julio-Pieper et al., 2012; Aguilera et al., 2013). As shown in
a recent study, spore-forming bacteria from mice and human
gut microbiota promote colonic serotonin biosynthesis, thus
regulating gastrointestinal motility and platelet function (Yano
et al., 2015). These literatures indicate the potential mechanism
of microbiota-mediated regulation of brain serotonergic system.
Other microbial metabolites, such as phytoestrogens, may also
bridge gut and brain functions. Equol is an estrogen produced by
the metabolism of dietary daidzein (a kind of soy isoflavone) by
some members of the gut microbiota in mammals (Han et al.,
2006; Shor et al., 2012). Equol-producing bacteria belonging
to the Eubacterium have been isolated from porcine feces (Yu
et al., 2008). Equol administration exerts neuroprotection against
cerebral ischemia/reperfusion injury in rats by decreasing brain
histological damage and inhibiting phospho-Src (Yu et al., 2014).
The intake of isoflavones has been found to improve memory
performance and cognitive behavior (Kennedy, 2014), although
FIGURE 2 | Potential regulation of microbiota on brain function in
small and large intestine. The microbiota composition differs between small
and large intestine, or mucosa and lumen. The rectangle objects are
represented as bacteria. The site-related pathways (in gray background) are
proposed according to the related discovery in this review.
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the mechanisms remain unclear. Therefore, these findings raise
the intriguing idea that gut-derived equol might affect the
function of the nervous system.
PERSPECTIVES AND CONCLUSION
The understanding of the role of the gut microbiota in
regulating brain health is increasing. Studies of rodent models
have expanded the concept of the microbiota–gut–brain axis.
However, the community and functions of the gut microbiota
are different in rodents and humans (Nguyen et al., 2015). Thus,
the findings of rodent research cannot be automatically translated
to humans. Even in humans, the microbial community varies
between different individuals. The difference in the composition
of the gut microbiota may influence the susceptibility of
individuals to illness (Aziz et al., 2013). Even though, studies of
rodent models can help to shed light on the potential existence of
a microbiota–gut–brain axis in humans.
As mentioned earlier, the spatial distribution of the microbiota
in the small and large intestine and in the lumen and mucosa
is different (Figure 2). Different sites in the gut form a niche-
specific environment that differ in pH, oxygen availability,
bacterial density, metabolite composition, and other aspects. It is
not clear whether the microbiota in the small and large intestine
and those in the lumen and mucosa contribute equally to the
microbiota–gut–brain axis. Resolving this issue is essential in
order to employ appropriate interventions, as the targeted sites
of various treatments differ. The absolute microbiota population
should also be quantified to define the potential contribution of
communities at different sites to the gut–brain axis.
Actually, many studies of human psychiatric disorders use
fecal microbiota as an indicator. In such studies, the sample
accessibility and ethnicity are major concerns. Generally, changes
in the composition of the gut microbiota are usually associated
with alterations in microbial gene expression, proteins, or
metabolites. These alterations make it difficult to identify the
key factors regulating the microbiota–gut–brain axis, especially
in studies using fecal analysis. A combined pipeline integrating
metagenomics and metabolomics may aid the discovery of
important changes beyond those in bacterial numbers.
Further, work is also needed to ascertain the possible
contribution of the gut microbiota to brain health. It will be
necessary to determine whether abnormal brain function is
dependent or independent of the gut microbiota. The existence
of microbiota dysbiosis in patients with psychiatric disorders
and the relationship between dysbiosis and hyperactivity of the
hypothalamic–pituitary–adrenal axis are other areas worthy of
further research. According to earlier work, both inflammation-
dependent and inflammation-independent pathways are
involved in improving brain health (Bercik et al., 2010). The
microbiota may function alone or in synergy with other factors,
such as inflammation, in regulating brain function. It is also
essential to determine whether changes in the composition of the
gut microbiota are the cause or the result of certain behaviors.
The latter can be elucidated by manipulating the composition
and number of the gut microbiota and examining the subsequent
effects on brain health.
Obviously, a healthy microbiota community is necessary to
maintain a healthy nervous system. Increasing evidences support
a peacekeeper role for the gut microbiota in regulating the
brain function, due to that the gut microbiota regulates nervous
system development, stress responses, anxiety, appetite, and
circadian rhythms. The depletion or disturbance of microbial
community is associated with psychiatric diseases. Treatments
aimed at restoring the normal gut microbiota and intestinal
homeostasis are associated with ameliorated neural responses. In
summary, identifying the alteration of the gut microbiota can
provide a clinical indicator and aid the diagnosis of patients with
psychiatric comorbidity.
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